Benzodiazepines, Inhalants, and Other Depressants; Introduction to Cocaine and Methylphenidate

Benzodiazepines and Other Depressants

Benzodiazepines

Benzodiazepines are a class of chemically synthesized depressant drugs commonly prescribed for anxiety, insomnia, and other conditions. Their effects and risks are important topics in psychopharmacology.

• Definition: Benzodiazepines are central nervous system depressants that enhance the effect of the neurotransmitter gamma-aminobutyric acid (GABA).

• Common Examples:

  • Diazepam (Valium)

  • Chlordiazepoxide (Librium)

  • Alprazolam (Xanax)

• Schedule IV: Most benzodiazepines are classified as Schedule IV drugs, indicating a lower potential for abuse compared to Schedule I-III substances.

Effects of Benzodiazepines

Benzodiazepines produce effects similar to alcohol and other depressants, primarily by reducing neural activity.

• Therapeutic Effects:

  • Enhances relaxation

  • Decreases anxiety

• Side Effects:

  • Drowsiness (sometimes desired)

  • Motor impairment at higher doses

  • Impaired memory formation

• Toxicity: At high doses, benzodiazepines can cause toxicity and even death.

Sedatives and Hypnotics

Prescription depressants are often categorized by their intended use: sedatives or hypnotics.

• Sedatives: Used to reduce anxiety and promote calmness. These are among the most widely prescribed anti-anxiety drugs and can be effective at doses that do not impair motor function.

• Hypnotics: Used to induce sleep. They often alter sleep patterns and decrease the amount of REM sleep, which is associated with dreaming.

Non-benzodiazepine Hypnotics

Non-benzodiazepine hypnotics are a group of drugs with different chemical structures but similar effects to benzodiazepines, primarily used for sleep disorders.

• Examples:

  • Zolpidem (Ambien)

  • Zaleplon (Sonata)

  • Eszopiclone (Lunesta)

• Effects: Help people fall asleep; considered safer than barbiturates but can still cause dependence and withdrawal.

• Schedule IV: These drugs are also classified as Schedule IV.

Pharmacology and Mechanism of Action

Benzodiazepines exert their effects by binding to GABA receptors in the brain, enhancing the inhibitory action of GABA.

• Mechanism: Facilitate GABAergic transmission, leading to reduced neuronal excitability.

• Brain Areas: Affect regions such as the amygdala and hypothalamus, which are involved in anxiety and stress responses.

Half-life and Medical Uses

The half-life of benzodiazepines varies widely, influencing their clinical use.

• Long Half-life: Used for chronic anxiety.

• Short Half-life: Used for sleep induction.

• Other Uses: Anticonvulsant (seizure prevention), management of alcohol withdrawal symptoms.

Prevalence and Types of Users

Benzodiazepine use is common, with a significant proportion of misuse.

• Prevalence: In 2018, about 12.6% of American adults used benzodiazepines; 17% of this was misuse.

• Misuse: Use without prescription or beyond prescribed duration.

Addiction Potential, Tolerance, and Withdrawal

Benzodiazepines can lead to dependence, tolerance, and withdrawal symptoms, especially with prolonged use.

• Addiction Potential: Increase dopamine in the nucleus accumbens by disinhibiting neurons in the ventral tegmental area (VTA).

• Tolerance: Higher doses required over time to achieve the same effect; cross-tolerance with alcohol and barbiturates.

• Withdrawal: Symptoms include insomnia, anxiety, tremors, convulsions, delirium, and seizures. Withdrawal may last up to 4 weeks and is more severe with short-acting drugs.

Related Drugs

• Rohypnol: A potent benzodiazepine sometimes used illicitly as a "date-rape" drug.

• GHB (Gamma Hydroxybutyric Acid): A naturally occurring substance with depressant effects, similar to GABA; can cause drowsiness, memory impairment, and unconsciousness at high doses.

Inhalants

Overview and Prevalence

Inhalants are substances that produce chemical vapors, which can be inhaled to induce psychoactive effects. Their use is less common but poses significant health risks.

• Prevalence: In 2018, 1.6% of American 12th graders reported using inhalants in the past year.

Types of Inhalants

• Gaseous Anesthetics: Medical gases such as halothane, enflurane, and nitrous oxide ("laughing gas").

• Volatile Solvents: Liquids that vaporize at room temperature, including paints, glues, and cements.

• Aerosols and Propellants: Spray paint, hairspray, lighter fluid, and other products packaged with gases.

Effects and Dangers

• Acute Effects: Euphoria, lightheadedness, drowsiness, disinhibition, and impulsiveness. High doses can cause unconsciousness.

• Health Risks: Suffocation, damage to kidneys, brain, and peripheral nerves.

Mechanism of Action

• GABA Receptors: Some inhalants enhance GABAergic activity, similar to benzodiazepines.

• NMDA Glutamate Receptors: Others decrease activity at NMDA receptors, similar to nitrous oxide.

Stimulant Drugs

General Properties

Stimulants increase excitement, alertness, motor activity, and elevate mood. They include a variety of drugs with different mechanisms.

• Examples: MDMA (Ecstasy), nicotine, caffeine, cocaine, amphetamines.

Cocaine

Cocaine is a powerful stimulant derived from the coca plant, traditionally used for its anesthetic and energizing properties.

• Source: Coca leaves from South America.

• Forms:

  • Cocaine Hydrochloride: Powder form, snorted.

  • Crack Cocaine: Smokable form, more potent and addictive.

  • Freebase Cocaine: Older smokable form, more dangerous.

• Routes of Administration: Oral (teas, soft drinks), intranasal (snorting), inhalation (smoking), injection.

• Mechanism: Blocks reuptake of dopamine (DA), leading to increased DA in the synapse and repeated activation of postsynaptic receptors.

Methylphenidate (Ritalin)

Methylphenidate is a synthetic stimulant similar to cocaine, primarily used to treat ADHD.

• Mechanism: Blocks reuptake of catecholamines (dopamine and norepinephrine).

• Administration: Usually taken orally, but can be snorted or injected.

Legal Status and Prevalence

• Schedule II: Both cocaine and methylphenidate are classified as Schedule II drugs, indicating high abuse potential but accepted medical use.

• Prevalence:

  • 2018: 1.5% annual prevalence for any cocaine, 0.6% for crack, 0.8% for methylphenidate misuse among 8th, 10th, and 12th graders.

  • 2024: 0.5% 30-day prevalence for cocaine among 12th graders.

• Usage Pattern: Cocaine users often report binge patterns—periods of heavy use followed by little or no use.

Historical Depressants and Barbiturates

Original Pharmaceutical Depressants

Early depressants had significant side effects and are no longer widely used.

• Chloral Hydrate: Induced sleep but caused stomach upset.

• Paraldehyde: Effective and safe but had an unpleasant taste and odor.

• Bromides: Used for sleep; long-term use led to motor problems, delirium, and psychosis.

Barbiturates

Barbiturates were once widely used as sleeping pills and anti-anxiety drugs but have a high risk of overdose and dependence.

• Effects: Decrease anxiety at low doses; anesthesia, coma, and death at high doses.

• Tolerance and Dependence: Common with prolonged use; overdoses frequent when mixed with alcohol.

Methaqualone

Methaqualone was marketed as a safer alternative to barbiturates but was found to be highly addictive and is now a Schedule I drug.

• Names: Quaaludes, Sopor.

• Effects: Similar to barbiturates but with a different chemical structure.

Nitrites

Medical and Recreational Use

Nitrites are used medically to treat chest pain by dilating blood vessels, but some are abused recreationally for their brief euphoric effects.

• Medical Use: Amyl nitrite for angina.

• Recreational Use: "Poppers" increase blood flow and cause lightheadedness.

Summary Table: Major Drug Classes Discussed

Drug Class	Main Examples	Mechanism of Action	Medical Use	Abuse Potential
Benzodiazepines	Valium, Librium, Xanax	Enhance GABAergic transmission	Anxiety, insomnia, seizures	Moderate (Schedule IV)
Non-benzodiazepine Hypnotics	Ambien, Sonata, Lunesta	GABA receptor modulation	Insomnia	Moderate (Schedule IV)
Barbiturates	Phenobarbital, Secobarbital	Enhance GABAergic transmission	Seizures, anesthesia	High (Schedule II/III)
Stimulants	Cocaine, Methylphenidate	Increase dopamine by blocking reuptake	ADHD, narcolepsy (methylphenidate)	High (Schedule II)
Inhalants	Nitrous oxide, solvents	GABA/NMDA receptor effects	Anesthesia (nitrous oxide)	Variable
Nitrites	Amyl nitrite	Vasodilation	Angina	Low to moderate